These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23358116)

  • 1. The formation of persister cells in stationary-phase cultures of Escherichia coli is associated with the aggregation of endogenous proteins.
    Leszczynska D; Matuszewska E; Kuczynska-Wisnik D; Furmanek-Blaszk B; Laskowska E
    PLoS One; 2013; 8(1):e54737. PubMed ID: 23358116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP-Dependent Persister Formation in Escherichia coli.
    Shan Y; Brown Gandt A; Rowe SE; Deisinger JP; Conlon BP; Lewis K
    mBio; 2017 Feb; 8(1):. PubMed ID: 28174313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence.
    Luidalepp H; Jõers A; Kaldalu N; Tenson T
    J Bacteriol; 2011 Jul; 193(14):3598-605. PubMed ID: 21602347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Integration Host Factor in Escherichia coli Persister Formation.
    Nicolau SE; Lewis K
    mBio; 2022 Feb; 13(1):e0342021. PubMed ID: 34982597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow-cytometry analysis reveals persister resuscitation characteristics.
    Mohiuddin SG; Kavousi P; Orman MA
    BMC Microbiol; 2020 Jul; 20(1):202. PubMed ID: 32640993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
    Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (p)ppGpp-Dependent Persisters Increase the Fitness of Escherichia coli Bacteria Deficient in Isoaspartyl Protein Repair.
    VandenBerg KE; Ahn S; Visick JE
    Appl Environ Microbiol; 2016 Sep; 82(17):5444-54. PubMed ID: 27371580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic slowdown caused by the deletion of
    Li Y; Chen X; Zhang W; Fang K; Tian J; Li F; Han M; Huang J; Sun T; Bai F; Cheng M; Xu Y
    Antimicrob Agents Chemother; 2024 Feb; 68(2):e0093723. PubMed ID: 38169282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persister formation in Staphylococcus aureus is associated with ATP depletion.
    Conlon BP; Rowe SE; Gandt AB; Nuxoll AS; Donegan NP; Zalis EA; Clair G; Adkins JN; Cheung AL; Lewis K
    Nat Microbiol; 2016 Apr; 1():16051. PubMed ID: 27572649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic basis of persister tolerance to aminoglycosides in Escherichia coli.
    Shan Y; Lazinski D; Rowe S; Camilli A; Lewis K
    mBio; 2015 Apr; 6(2):. PubMed ID: 25852159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition.
    Aedo SJ; Orman MA; Brynildsen MP
    BMC Microbiol; 2019 Jun; 19(1):140. PubMed ID: 31234796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the Effects of Osmolytes and Environmental pH on Bacterial Persisters.
    Karki P; Mohiuddin SG; Kavousi P; Orman MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Screening of a Promoter Library Reveals New Persister Mechanisms in Escherichia Coli.
    Mohiuddin SG; Massahi A; Orman MA
    Microbiol Spectr; 2022 Feb; 10(1):e0225321. PubMed ID: 35196813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth arrest or drug target inactivity is not sufficient for persister formation in E. coli.
    Xu Y; Cui P; Zhang Y; Zhang W
    Discov Med; 2020; 29(157):103-112. PubMed ID: 33002406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persister Escherichia coli Cells Have a Lower Intracellular pH than Susceptible Cells but Maintain Their pH in Response to Antibiotic Treatment.
    Goode O; Smith A; Zarkan A; Cama J; Invergo BM; Belgami D; Caño-Muñiz S; Metz J; O'Neill P; Jeffries A; Norville IH; David J; Summers D; Pagliara S
    mBio; 2021 Aug; 12(4):e0090921. PubMed ID: 34281389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Evolution of Escherichia coli Persister Levels Using Cyclic Antibiotic Treatments.
    Van den Bergh B; Michiels JE; Michiels J
    Methods Mol Biol; 2016; 1333():131-43. PubMed ID: 26468106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell division in Escherichia coli cultures monitored at single cell resolution.
    Roostalu J; Jõers A; Luidalepp H; Kaldalu N; Tenson T
    BMC Microbiol; 2008 Apr; 8():68. PubMed ID: 18430255
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Mohiuddin SG; Massahi A; Orman MA
    mBio; 2022 Feb; 13(1):e0218721. PubMed ID: 35038905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dynamic Transition of Persistence toward the Viable but Nonculturable State during Stationary Phase Is Driven by Protein Aggregation.
    Dewachter L; Bollen C; Wilmaerts D; Louwagie E; Herpels P; Matthay P; Khodaparast L; Khodaparast L; Rousseau F; Schymkowitz J; Michiels J
    mBio; 2021 Aug; 12(4):e0070321. PubMed ID: 34340538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.
    Cameron DR; Shan Y; Zalis EA; Isabella V; Lewis K
    J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29941425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.